This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 2 EPO patents. Top assignees: Beijing Tiantan Hospital, Capital Medical University, Nanjing Baixinyu Pharmaceutical Co. Ltd.. Active years: 2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2024
Title: The Innovations of Xingquan Zhao
Introduction
Xingquan Zhao is a notable inventor based in Beijing, China. He has made significant contributions to the field of pharmaceuticals, particularly with his innovative work on edaravone. His research and inventions have the potential to impact the medical community positively.
Latest Patents
Xingquan Zhao holds a patent for an edaravone pharmaceutical composition. This invention discloses a sublingual preparation that contains edaravone or a salt thereof along with mannitol. The sublingual administration method can effectively avoid the first-pass effect of the liver, providing advantages such as good stability and convenience of transport and use. This innovation represents a significant advancement in the delivery of edaravone.
Career Highlights
Throughout his career, Xingquan Zhao has worked with several reputable institutions. He has been associated with Beijing Tiantan Hospital and Capital Medical University, where he has contributed to various research projects. Additionally, he has worked with Nanjing Baixinyu Pharmaceutical Co. Ltd., further enhancing his experience in the pharmaceutical industry.
Collaborations
Xingquan Zhao has collaborated with notable professionals in his field, including Yilong Wang and Yongjun Wang. These collaborations have likely enriched his research and contributed to the development of his innovative pharmaceutical compositions.
Conclusion
Xingquan Zhao's work in the pharmaceutical field, particularly with his patent on edaravone, showcases his dedication to innovation and improvement in medical treatments. His contributions are valuable to the ongoing advancements in pharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile